Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 655M | 598M | 554M | 581M |
Cost of revenue | 166M | 139M | 134M | 140M |
Gross profit | 489M | 459M | 420M | 441M |
Operating expense | ||||
Research & development | 153M | 149M | 149M | 145M |
Selling general and admin | 347M | 319M | 340M | 340M |
Other operating expenses | — | — | — | — |
Operating income | -11M | -9M | -69M | -44M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 5M | 5M | 8M | 9M |
Other income expense | 18M | 22M | 26M | 33M |
Pretax income | 2M | 8M | -51M | -20M |
Tax provision | 0 | 0 | 1M | 0 |
Net income | 2M | 8M | -52M | -20M |
Basic EPS | 0.0 | 0.0 | -0.2 | -0.1 |
Diluted EPS | 0.0 | 0.0 | -0.2 | -0.1 |
Basic average shares | 241.1M | 242.3M | 236.3M | 232.5M |
Diluted average shares | 241.1M | 256.2M | 236.3M | 232.5M |
EBITDA | 76M | 80M | 21M | 55M |
Net income from continuing op. | 2M | 8M | -52M | -20M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |